Cetirizine hydrochloride and Upper respiratory tract infection - a phase IV clinical study of FDA data
Summary:
Upper respiratory tract infection is reported as a side effect among people who take Cetirizine hydrochloride (cetirizine hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Orencia, and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people have Upper respiratory tract infection when taking Cetirizine hydrochloride. It is created by eHealthMe based on reports of 33,393 people who have side effects when taking Cetirizine hydrochloride from the FDA, and is updated regularly.
What is Cetirizine hydrochloride?
Cetirizine hydrochloride has active ingredients of cetirizine hydrochloride. It is often used in allergies. eHealthMe is studying from 34,908 Cetirizine hydrochloride users. Check the latest studies of Cetirizine hydrochloride.
What is Upper respiratory tract infection?
Upper respiratory tract infection is found to be associated with 1,903 drugs and 1,769 conditions by eHealthMe. Check the latest studies of Upper respiratory tract infection.
33,393 people reported to have side effects when taking Cetirizine hydrochloride.
Among them, 870 people (2.61%) have Upper respiratory tract infection.

Among these 870 people:
How long have people been on Cetirizine hydrochloride when they have Upper respiratory tract infection? *
What is the gender of people who have Upper respiratory tract infection when taking Cetirizine hydrochloride? *
What is the age of people who have Upper respiratory tract infection when taking Cetirizine hydrochloride? *
What are other drugs people take besides Cetirizine hydrochloride? *
What are other side effects people have besides Upper respiratory tract infection? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Cetirizine hydrochloride and have Upper respiratory tract infection?
- Check whether Upper respiratory tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Cetirizine hydrochloride:
- Cetirizine hydrochloride (34,908 reports)
Upper respiratory tract infection treatments and more:
- Upper respiratory tract infection (64,928 reports)
How severe was Upper respiratory tract infection and when was it recovered:
Expand to all the drugs that have ingredients of cetirizine hydrochloride:
- Upper respiratory tract infection and drugs with ingredients of cetirizine hydrochloride (2,409 reports)
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Cetirizine hydrochloride:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Upper respiratory tract infection:
- Upper respiratory tract infection (1,903 drugs)
Browse all the conditions that are associated with Upper respiratory tract infection:
- Upper respiratory tract infection (1,769 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on cetirizine hydrochloride (the active ingredients of Cetirizine hydrochloride) and Cetirizine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Lexapro cause Agoraphobia? - now
- Abasia and drugs of ingredients of somatropin recombinant - a second ago
- Nicotine and Carboplatin drug interactions for men aged 60+ - a second ago
- Prograf and Consciousness - Decreased for Women aged 50-59 - 3 seconds ago
- Prograf and Stuporous for Women aged 50-59 - 4 seconds ago
- Prograf and Mental Status - Decreased for Women aged 50-59 - 4 seconds ago
- Prograf and Loss Of Alertness for Women aged 50-59 - 4 seconds ago
- Prograf and Decreased Consciousness for Women aged 50-59 - 4 seconds ago
- Prograf and Coma for Women aged 50-59 - 5 seconds ago
- Prograf and Changes In Consciousness for Women aged 50-59 - 5 seconds ago